Submarine patent

Last updated

A submarine patent is a patent whose issuance and publication are intentionally delayed by the applicant for a long time, which can be several years, or a decade. [1] [2] [3] This strategy requires a patent system where, first, patent applications are not published, and, second, patent term is measured from grant date, not from priority or filing date. In the United States, patent applications filed before November 2000 were not published and remained secret until they were granted. Analogous to a submarine, submarine patents could remain "under water" for long periods until they "emerged", surprising the relevant market. Persons or companies making use of submarine patents are sometimes referred to as patent pirates. [4] [5]

Contents

The phrase is occasionally used more generally for any patent used in patent ambush. [6] [7] [8] [9]

Causes

"Prior to requiring the publication of [U.S. patent] applications, the public would not learn of a patent until after it issued, which is often several years after the application was filed. Some patentees took advantage of this practice to the extreme (with ‘‘submarine’’ patents), and intentionally delayed their patents issuance, and thus publication, of the patent for several years to allow potentially infringing industries to develop and expand, having no way to learn of the pending application."
—U.S. Committee on the Judiciary, 2008 [1]

After the United States signed the TRIPS Agreement of the WTO in 1995, the standard patent term of 20 years under United States patent law has been measured from the original filing or priority date, rather than (as was previously the case) the date of issuance. This has significantly reduced the previous potential for submarine patent practices. Some submarine patents may also result from pre-1995 filings that have yet to be granted and will remain unpublished until issuance. Submarine patents are also weaker in jurisdictions such as US Federal Courts, in which they may be considered to be a procedural laches : a delay in enforcing one's rights that causes those rights to be lost.

In the past, when the life of a U.S. patent was 17 years from the date it was granted, submarine patents could issue decades after the initial filing date. Therefore, an applicant for a U.S. patent could benefit by delaying the issuance, and thus expiration date, of a patent through the simple, but relatively costly, expedient of filing a succession of continuation applications.[ clarification needed ] Some submarine patents emerged as much as 40 years after the date of filing of the corresponding application. [10] During the extended prosecution period the claims of the patent could be modified to more closely match whatever technology or products had become the industry standard.

Prior to changes in US patent law in 1995 and 1999, the content of patent applications was kept secret during the patent approval phase. Currently, the majority of U.S. patent applications are published within 18 months of the filing date (35 U.S.C. 122). However, the applicant can explicitly certify that they do not intend to file a corresponding patent outside the U.S. at the time they file the patent, and keep the application secret. The applicant can change their mind within the first year, but the application is then published. For continuation applications which claim priority to a previously filed application, the publication is six months after the new filing date. The changes to U.S. patent law that introduced publication at 18 months also changed the duration of the patent to 20 years from the filing date of the earliest patent application in any chain of continuation patent applications. As a result, there is little benefit in postponing the grant of the patent. The enforceable life of the patent can no longer be shifted into the period when a technology has become more widely adopted, and the patent applicant must abandon the chance of foreign patent protection if he is to maintain patent secrecy beyond the 18-month period. In a 2006 report the National Academy of Sciences has recommended that "in all cases, applications should be published during patent examinations". [11]

Notable submarine patent owners

A notable case of a single submarine patent is the George B. Selden automobile design, applied for in 1879 and issued in 1895, which led to the creation of the Association of Licensed Automobile Manufacturers. [12] [13] [14]

Gilbert Hyatt was awarded a patent claiming an invention pre-dating both Texas Instruments and Intel, describing a "microcontroller". [15] The patent was later invalidated, but not before substantial royalties were paid out. [16] [17] He also still has two even wider patents still pending, also dating from the same period. [18]

Jerome H. Lemelson filed many applications that became submarine patents. [19] He and his heirs have collected over $1.3 billion (U.S.) in royalties. [20] In 2004 Lemelson's estate was defeated in a notable court case involving Symbol Technologies and Cognex Corporation, which sought (and received) a ruling that 76 claims under Lemelson's machine-vision patents were unenforceable. [20] The plaintiff companies, with the support of dozens of industry supporters, spent millions on this landmark case. The ruling was upheld on September 9, 2005 by a three-judge panel of the U.S. Court of Appeals for the Federal Circuit under the doctrine of laches , citing "unreasonably long … delays in prosecution." [21] [22] Lemelson's estate appealed for a review by the full circuit en banc. On November 16, 2005, the full court declined to review the case, and, citing "prejudice to the public as a whole", extended the original unenforceability ruling to all claims under the patents in question. [23] [24]

See also

Related Research Articles

<span class="mw-page-title-main">Laches (equity)</span> Unreasonable delay by a plaintiff in bringing their claim

In common-law legal systems, laches is a lack of diligence and activity in making a legal claim, or moving forward with legal enforcement of a right, particularly in regard to equity. This means that it is an unreasonable delay that can be viewed as prejudicing the opposing party. When asserted in litigation, it is an equity defense, that is, a defense to a claim for an equitable remedy.

Jerome "Jerry" Hal Lemelson was an American engineer, inventor, and patent holder. Several of his inventions and works in the fields in which he patented have made possible, either wholly or in part, innovations like automated warehouses, industrial robots, cordless telephones, fax machines, videocassette recorders, camcorders, and the magnetic tape drive used in Sony's Walkman tape players. Lemelson's 605 patents made him one of the most prolific inventors in American history.

Novelty is one of the patentability requirement for a patent claim, whose purpose is to prevent issuing patents on known things, i.e. to prevent public knowledge from being taken away from the public domain.

Under United States patent law, a continuing patent application is a patent application that follows, and claims priority to, an earlier-filed patent application. A continuing patent application may be one of three types: a continuation, divisional, or continuation-in-part. Although continuation and continuation-in-part applications are generally available in the U.S. only, divisional patent applications are also available in other countries, as such availability is required under Article 4G of the Paris Convention.

Patent prosecution describes the interaction between applicants and their representatives, and a patent office with regard to a patent, or an application for a patent. Broadly, patent prosecution can be split into pre-grant prosecution, which involves arguing before, and sometimes negotiation with, a patent office for the grant of a patent, and post-grant prosecution, which involves issues such as post-grant amendment and opposition.

Under United States patent law, the term of patent, provided that maintenance fees are paid on time, is 20 years from the filing date of the earliest U.S. or international (PCT) application to which priority is claimed.

Sufficiency of disclosure or enablement is a patent law requirement that a patent application disclose a claimed invention in sufficient detail so that the person skilled in the art could carry out that claimed invention. The requirement is fundamental to patent law: a monopoly is granted for a given period of time in exchange for a disclosure to the public how to make or practice the invention.

The term of a patent is the maximum time during which it can be maintained in force. It is usually expressed in a number of years either starting from the filing date of the patent application or from the date of grant of the patent. In most patent laws, annuities or maintenance fees have to be regularly paid in order to keep the patent in force. Thus, a patent may lapse before its term if a renewal fee is not paid in due time.

The USA is considered to have the most favorable legal regime for inventors and patent owners in the World. Under United States law, a patent is a right granted to the inventor of a (1) process, machine, article of manufacture, or composition of matter, (2) that is new, useful, and non-obvious. A patent is the right to exclude others, for a limited time from profiting of a patented technology without the consent of the patent-holder. Specifically, it is the right to exclude others from: making, using, selling, offering for sale, importing, inducing others to infringe, applying for an FDA approval, and/or offering a product specially adapted for practice of the patent.

<span class="mw-page-title-main">Concurrent use registration</span> Federal trademark registration of the same trademark to two or more unrelated parties

A concurrent use registration, in United States trademark law, is a federal trademark registration of the same trademark to two or more unrelated parties, with each party having a registration limited to a distinct geographic area. Such a registration is achieved by filing a concurrent use application and then prevailing in a concurrent use proceeding before the Trademark Trial and Appeal Board ("TTAB"), which is a judicial body within the United States Patent and Trademark Office ("USPTO"). A concurrent use application may be filed with respect to a trademark which is already registered or otherwise in use by another party, but may be allowed to go forward based on the assertion that the existing use can co-exist with the new registration without causing consumer confusion.

A patent application is a request pending at a patent office for the grant of a patent for an invention described in the patent specification and a set of one or more claims stated in a formal document, including necessary official forms and related correspondence. It is the combination of the document and its processing within the administrative and legal framework of the patent office.

This is a list of legal terms relating to patents and patent law. A patent is not a right to practice or use the invention claimed therein, but a territorial right to exclude others from commercially exploiting the invention, granted to an inventor or his successor in rights in exchange to a public disclosure of the invention.

Double patenting is the granting of two patents for a single invention, to the same proprietor and in the same country or countries. According to the European Patent Office, it is an accepted principle in most patent systems that two patents cannot be granted to the same applicant for one invention. However, the threshold for double patenting varies from jurisdiction to jurisdiction.

Gerald D. Hosier is an American intellectual property (IP) attorney and a patent litigator. In 2000, Forbes magazine declared him the highest-paid lawyer in America, with an annual income of $40 million.

The history of United States patent law started even before the U.S. Constitution was adopted, with some state-specific patent laws. The history spans over more than three centuries.

<span class="mw-page-title-main">Leahy–Smith America Invents Act</span>

The Leahy–Smith America Invents Act (AIA) is a United States federal statute that was passed by Congress and was signed into law by President Barack Obama on September 16, 2011. The law represents the most significant legislative change to the U.S. patent system since the Patent Act of 1952 and closely resembles previously proposed legislation in the Senate in its previous session.

Brenner v. Manson, 383 U.S. 519 (1966), was a decision of the United States Supreme Court in which the Court held that a novel process for making a known steroid did not satisfy the utility requirement, because the patent applicants did not show that the steroid served any practical function. The Court ruled that "a process patent in the chemical field, which has not been developed and pointed to the degree of specific utility, creates a monopoly of knowledge which should be granted only if clearly commanded by the statute." Practical or specific utility, so that a "specific benefit exists in currently available form" is thus the requirement for a claimed invention to qualify for a patent.

The Washington Redskins trademark dispute was a legal effort by Native Americans to define the term "redskin" to be an offensive and pejorative racial slur to deprive the owners of the NFL's Washington Redskins of the ability to maintain federal trademark protection for the name. These efforts had primarily been carried forward in two cases brought before the U.S. Patent and Trademark Office (USPTO). While prevailing in the most recent case in which the trademarks were cancelled, petitioners withdrew for further litigation now that the legal issue has become moot due to a decision in another case which found the relevant portion of the trademark law to be an unconstitutional infringement on freedom of speech.

Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), was a Supreme Court case, which decided, that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated.” However, as a "bizzare conciliatory prize" the Court allowed patenting of complementary DNA, which contains exactly the same protein-coding base pair sequence as the natural DNA, albeit with introns removed.

Peter v. NantKwest Inc., 589 U.S. ___ (2019), was a United States Supreme Court case from the October 2019 term.

References

  1. 1 2 U.S. Committee on the Judiciary, Calendar No. 563, 110th Congress Report, 2d Session, U.S Senate, 110–259, The Patent Reform Act of 2007, January 24, 2008, footnote 112.
  2. ↑ Gabriel P. Katona, The Myth of Submarine Patents, Pandab online newsletter, August 10, 1998. Consulted on March 28, 2010.
  3. ↑ Gene Quinn, Submarine Patents Alive and Well: Tivo Patents DVR Scheduling, IPWatchdog, February 19, 2010. Consulted on March 28, 2010.
  4. ↑ United States House of Representatives Committee on the Judiciary, Subcommittee on Courts and Intellectual Property, Hon. Howard Coble, North Carolina, Chairman, Hearing on the "21st Century Patent System Improvement Act", H.R. 400, Summary of Testimony of Harold C. Wegner, Professor of Law, George Washington University Law School, retrieved on June 10, 2006
  5. ↑ Janine Robben, Son of Invention, Willamette Week Online, August 25, 2004
  6. ↑ Josh Rosenblum, Paying for Patents, Legal Affairs, May/June 2005. Consulted on March 28, 2010.
  7. ↑ Archived February 28, 2009, at the Wayback Machine
  8. ↑ Ozer, Jan (2010-03-04). "Ogg, MPEG LA, and Submarine Patents". Streaming Media Magazine. Retrieved 2011-07-26.
  9. ↑ Paul, Ryan (2009-07-05). "Decoding the HTML 5 video codec debate". Ars Technica. Retrieved 2011-07-26.
  10. ↑ "Of course, there are a few original patent applications that take decades to issue as well, but this is due to secrecy restrictions, interferences, Board, district court or Federal Circuit appeals. See, e.g., U.S. Patent No. 5,132,080 (an original application was filed November 28, 1944 and the patent was not permitted to issue until July 21, 1992 due to secrecy restrictions); U.S. Patent No. 6,097,812 (filed July 25, 1933 and delayed due to secrecy until August 1, 2000); U.S. Patent No. 6,130,946 (filed October 23, 1936 and delayed due to secrecy until October 10, 2000). Pursuant to 35 U.S.C. §181, the Commissioner of the PTO must withhold the granting of any patent “[w]henever publication or disclosure ... by the grant of a patent on an invention in which the Government has a property interest might, in the opinion of the head of the interested Government agency, be detrimental to the national security.” Id. Although §181 only permits the Commissioner to delay patent issuance for up to one year, the secrecy can be renewed for an unlimited number of one year periods if it is in the interest of national security." in Mark A. Lemley, Kimberly A. Moore, Ending Abuse of Patent Continuations, Boalt Working Papers in Public Law (University of California, Berkeley), Year 2003, Paper 20, page 9, footnote 27.
  11. ↑ The National Academies, "Changes Needed to Improve Operation of U.S. Patent System". Archived from the original on February 17, 2006. Retrieved February 17, 2006.
  12. ↑ Flink, p. 51 "Probably the most absurd action in the history of patent law was the granting of United States patent number 549,160 on November 5, 1895, to George B. Selden. a Rochester, New York, patent lawyer and inventor, for an 'improved road engine' powered by 'a liquid-hydrocarbon engine of the compression type'."
  13. ↑ Flink, p. 51 "His own patent application was filed in 1879. He then used evasive legal tactics to delay the patent's acceptance until conditions seemed favorable for commercial exploitation."
  14. ↑ Borth, Christy. Masters of Mass Production, pp. 38, 152, Bobbs-Merrill Co., Indianapolis, IN, 1945.
  15. ↑ Hyatt, Gilbert P., "Single chip integrated circuit computer architecture", Patent 4942516, issued July 17, 1990
  16. ↑ "The Gilbert Hyatt Patent". intel4004.com. Federico Faggin. Retrieved 2009-12-23.
  17. ↑ Crouch, Dennis (1 July 2007). "Written Description: CAFC Finds Prima Facie Rejection (Hyatt v. Dudas (Fed. Cir. 2007))". Patently-O blog. Retrieved 2009-12-23.
  18. ↑ "Inventor Waits 43 Years for Another Chance to Shock Tech", Feb 24 2014, Bloomberg Business
  19. ↑ W. F. Heinze, Dead Patents Walking, IEEE Spectrum (2002). Consulted on November 26, 2009.
  20. 1 2 Susan Hansen, Breaking the (Bar) Code, IP Law & Business, March 2004
  21. ↑ United States Court of Appeals for the Federal Circuit, 04-1451, Symbol Technologies, Inc. et al. v. Lemelson Medical, Education & Research Foundation, LP Archived 2010-02-16 at the Wayback Machine , September 9, 2005
  22. ↑ Appeals Court confirms invalidity of bar code patents, OUT-LAW News, September 12, 2005
  23. ↑ United States Court of Appeals for the Federal Circuit, 04-1451, Symbol Technologies, Inc. et al. v. Lemelson Medical, Education & Research Foundation, LP Archived 2009-08-27 at the Wayback Machine , November 16, 2005
  24. ↑ The patents at issue are: U.S. Patent 4,338,626 , U.S. Patent 4,511,918 , U.S. Patent 4,969,038 , U.S. Patent 4,979,029 , U.S. Patent 4,984,073 , U.S. Patent 5,023,714 , U.S. Patent 5,067,012 , U.S. Patent 5,119,190 , U.S. Patent 5,119,205 , U.S. Patent 5,128,753 , U.S. Patent 5,144,421 , U.S. Patent 5,249,045 , U.S. Patent 5,283,641 , U.S. Patent 5,351,078 .
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.